Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Nowadays data are often timestamped, thus, when analysing the events which may occur several times (recurrent events), it is desirable to model the whole dynamics of the counting process rather than to focus on a total number of events. Such kind of data can be encountered in hospital readmissions, disease recurrences or repeated failures of industrial systems. Recurrent events can be analysed in the counting process framework, as in the Andersen-Gill model, assuming that the baseline intensity depends on time and on covariates, as in the Cox model. However, observed covariates are often insufficient to explain the observed heterogeneity in the data. We propose a mixture model for recurrent events, allowing to account for the unobserved heterogeneity and to perform clustering of individuals (unsupervised classification allowing to partition of the heterogeneous data according to unobserved, or latent, variables). Within each cluster, the recurrent event process intensity is specified parametrically and is adjusted for covariates. Model parameters are estimated by maximum likelihood using the EM algorithm; the BIC criterion is adopted to choose an optimal number of clusters. The model feasibility is checked on simulated data. Real data on hospital readmissions of elderly people, which motivated the development of the proposed clustering model, are analysed. The obtained results allow a fine understanding of the recurrent event process in each cluster.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12404095PMC
http://dx.doi.org/10.1080/02664763.2025.2452966DOI Listing

Publication Analysis

Top Keywords

recurrent events
16
counting process
8
hospital readmissions
8
recurrent event
8
event process
8
data
7
model
7
events
6
recurrent
5
clustering recurrent
4

Similar Publications

Introduction: Etripamil is a fast-acting intranasally self-administered calcium-channel blocker developed for termination of paroxysmal supraventricular tachycardia (PSVT). Prior studies have demonstrated safety and efficacy of etripamil for PSVT termination following an initial medically supervised test dose during sinus rhythm. NODE-303 is an open-label, single-arm study that evaluated etripamil for multiple, at-home PSVT episodes, without test dose before first use.

View Article and Find Full Text PDF

Background: Tildrakizumab has demonstrated high efficacy and a good long-term safety profile, including low malignancy rates, in Phase III trials with 5-year extension. Despite these data, the real-world evidence on patients with psoriasis and a history of cancer is limited.

Objectives: To assess the efficacy and safety of tildrakizumab in a cohort of patients with moderate-to-severe psoriasis and a previous or current history of neoplasia.

View Article and Find Full Text PDF

Objective: This study aimed to identify key predictors of uterine fibroid (UF) recurrence following laparoscopic myomectomy (LM) in reproductive-age women and to construct a predictive nomogram to support individualized clinical decision-making.

Methods: This retrospective cohort study included 459 women who underwent LM. Recurrence of UFs and risk of recurrence were analyzed.

View Article and Find Full Text PDF

Background: People living with HIV (PLWH) have a higher risk of herpes zoster (HZ) reactivation and postherpetic neuralgia (PHN) compared to general population. Our study aims to evaluate prevalence of HZ reactivation and PHN after vaccination with recombinant vaccine (RZV) in a population living with HIV, and to identify risk factors associated with recurrence.

Methods: We conducted an observational study, enrolling all PLWH ≥18 years old vaccinated with RZV from January 2022 to December 2023.

View Article and Find Full Text PDF

Deciphering the molecular landscape of acute myeloid leukemia initiation and relapse: a systems biology approach.

Med Oncol

September 2025

Division of Hematology and Blood Bank, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

Acute Myeloid Leukemia (AML) patient-derived Mesenchymal Stem Cells (MSCs) behave differently than normal ones, creating a more protective environment for leukemia cells, making relapse harder to prevent. This study aimed to identify prognostic biomarkers and elucidate relevant biological pathways in AML by leveraging microarray data and advanced bioinformatics techniques. We retrieved the GSE122917 dataset from the NCBI Gene Expression Omnibus and performed differential expression analysis (DEA) within R Studio to identify differentially expressed genes (DEGs) among healthy donors, newly diagnosed AML patients, and relapsed AML patients.

View Article and Find Full Text PDF